Table 2.
Endpoints | Variables | HR (95% CI) | P-value a |
---|---|---|---|
OS | Age | 1.755(1.270-2.425) | 0.001 |
CRP/Alb ratio | 1.394(1.004-1.937) | 0.048 | |
T classification b | < 0.001 | ||
T1 | Reference | ||
T2 | 3.095(1.313-7.297) | 0.010 | |
T3 | 3.077(1.404-6.742) | 0.005 | |
T4 | 6.136(2.765-13.619) | < 0.001 | |
N classification b | < 0.001 | ||
N0 | Reference | ||
N1 | 1.723 (0.886-3.352) | 0.109 | |
N2 | 2.876 (1.404-5.889) | 0.004 | |
N3a | 5.919 (2.307-15.187) | < 0.001 | |
N3b | 7.107 (3.452-14.630) | < 0.001 | |
DMFS | CRP/Alb ratio | 1.545(1.124-2.122) | 0.007 |
T classification b | 0.018 | ||
T1 | Reference | ||
T2 | 1.295(0.697-2.406) | 0.412 | |
T3 | 1.229(0.728-2.074) | 0.436 | |
T4 | 2.055(1.178-3.583) | 0.011 | |
N classification b | < 0.001 | ||
N0 | Reference | ||
N1 | 2.047(1.054-3.979) | 0.035 | |
N2 | 4.123(2.045-8.315) | < 0.001 | |
N3a | 7.437(2.977-18.579) | < 0.001 | |
N3b | 7.195(3.479-14.883) | < 0.001 | |
DFS | Age | 1.302(1.023-1.657) | 0.032 |
CRP/Alb ratio | 1.235(0.973-1.568) | 0.083 | |
T classification b | 0.001 | ||
T1 | Reference | ||
T2 vs T1 | 1.445(0.910-2.294) | 0.118 | |
T3 vs T1 | 1.331(0.899-1.972) | 0.154 | |
T4 vs T1 | 2.164(1.423-3.292) | < 0.001 | |
N classification b | < 0.001 | ||
N0 | Reference | ||
N1 | 1.948(1.241-3.059) | 0.004 | |
N2 | 2.926(1.785-4.798) | < 0.001 | |
N3a | 4.207(1.971-8.978) | < 0.001 | |
N3b | 4.985(2.952-8.420) | < 0.001 |
Abbreviations: HR, hazard ratio; CI, confidence interval; OS, overall survival; DMFS, distant metastasis-free survival; DFS, disease-free survival.
a P values were calculated with an adjusted Cox proportional hazards model.
b According to the 7th edition of the UICC/AJCC staging system.